Replies to post #13507 on RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

It may be that the 'inactive' component takes away the time pressure of the regulations, I'm not sure. Cortex certainly seemed to be anticipating something for a while. As I mentioned, I don't think Cortex is worse off for not getting one, they may be better off, because the FDA's case is so flimsy that they'd have to jazz it up just to put it in writing--and that would make it more difficult to back off, if that were ever to come to pass.

I'm not aware of it happening before, but companies would not necessarily bring it up in public. I don't think it is neglect/incompetence per se--though the decision itself was incompetent IMHO. Now, it's more a case of--we aren't sure what to say, and there's no particular need to say anything, so why shouldnt we just move on to the hundreds of other things on our regulatory plate?

NeuroInvestment

[jddividends]

I've always admitted to not being a scientific person nor one who totally understands Bio tech investing in general. I consider myself to be an investor(who is'nt doing so well)but understands the diseases that exist in our world and the promise that some companies provide in order to cure/improve the conditions of such illnesses.

That is what brought me to Cortex and investing in their (and my) future.

All that being said--- I find it impossible to believe that the FDA is'nt legally required to provide in writing their decision and findings. I also find it hard to believe that in this day and age of fedex and "overnights" that this info was'nt received the day after the decision.

I have'nt been keeping up on the posts regarding all of this and I may be re-hashing old stuff--- I'm trying to move on with my portfolio--- but realizing that the FDA has come very close to putting an honest company(I hope) out of business does piss me off and if any corruption exists it needs to be exposed!!!

Sincerely, JD